Found 2142 matching trials
A Trial of Conversion Treatment of HAIC Combined With Camrelizumab and Apatinib for Unresected Hepatocellular Carcinoma PHASE2 The study is being conducted to evaluate the efficacy and safety of convers...
Show More Location
Shandong Cancer Hospital and Institute
Learn More & Join Trial
JSKN003 Combined Treatment of HER2-positive Gastric Cancer PHASE2 This study is designed to evaluate the safety and efficacy of JSKN003 combi...
Show More Location
Multiple Locations
Learn More & Join Trial
CGA Guided Ultrafractionated RT and First-line Systemic Treatment in Elderly or Frail Patients with MCRC PHASE2 This is a prospective, multicentre, cohort study. For cohort 1(CGA cohort),...
Show More Location
Multiple Locations
Learn More & Join Trial
BrUOG 295: Adjuvant FOLFOX-A For Resected Pancreatic Cancer: A Phase II Brown University Oncology Research Group Trial PHASE2 The investigators preliminary data suggests that FOLFOX-A may have equal or...
Show More Learn More & Join Trial
A Platform Trial for Personalized and Adaptive Therapies in Hepatocellular Carcinoma PHASE2 This is a phase II, multi-arm, Bayesian adaptive platform trial designed to...
Show More Location
Zhongshan Hospital, Fudan University
Learn More & Join Trial
Cadonilimab Combination With Chemotherapy With or Without AK117 in Resectable Gastric or Gastroesophageal Junction Adenocarcinoma PHASE2 This trial is a Phase II study. All patients are resectable Gastric or Gast...
Show More Location
Tianjin Provincial Tumor Hospital
Learn More & Join Trial
GTI-2040, Oxaliplatin, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer or Other Solid Tumors PHASE1 This phase I trial is studying the side effects and best dose of capecitabi...
Show More Learn More & Join Trial
A Study Comparing BL-B01D1 With Treatment of Physician's Choice in Patients With Locally Advanced or Metastatic Biliary Tract Cancer After Failure of Platinum-based Chemotherapy(PANKU-BTC01) PHASE3 This trial is a registrational Phase III, randomized, open-label, multicent...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial
Isolated Hepatic Perfusion With Melphalan Followed by Combination Chemotherapy in Treating Patients With Unresectable Liver Metastases From Colorectal Cancer PHASE2 RATIONALE: Drugs used in chemotherapy, such as melphalan, leucovorin, oxali...
Show More Location
Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support
Learn More & Join Trial
First-line Therapy in Metastatic PDAC PHASE2 The overarching hypothesis of this trial is that the NAPOLI regimen and alt...
Show More Location
Klinikum der Universitaet Muenchen - Campus Grosshadern
Learn More & Join Trial